Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression

Cancer Research

Volumn 56, Issue 15, 1996, Pages 3436-3440

  Mazure, Nathalie M ^a   Chen, Eunice Y ^a   Yeh, Patricia ^a   Laderoute, Keith R ^b   Giaccia, Amato J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; OXYGEN; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; HYPOXIA; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROMOTER REGION; RAT; REPORTER GENE;

3T3 CELLS; ANIMALS; CELL HYPOXIA; CELL TRANSFORMATION, NEOPLASTIC; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION; GENES, RAS; LYMPHOKINES; MICE; PROMOTER REGIONS (GENETICS); RAS PROTEINS; RATS; RNA, MESSENGER; STRESS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0029681850     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Folkman, J., and Shing, Y. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
2. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
3. Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., and Giaccia, A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (Lond.), 379: 88-91, 1996.
4. Rak, J., Mitsuhashi, Y., bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R. S. Mutant ras oncogenes up-regulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res., 5: 4575-4580, 1995.
5. Risau, W., Drexler, H., Mironov, V., Smits, A., Siegbalin, A., Funa, K., and Heldin, C-H. Platelet-derived growth factor is angiogenic in vivo. Growth Factors, 7: 261-266, 1992.
6. Mukhopadhyay, D., Tsiokas, L., Zhou, X., Foster, D., Brugge, J. S., and Sukhatme, V. P. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature (Lond.), 375: 577-581, 1995.
7. Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B., and Marme, D. Both v-H-ras and v-raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem., 270: 25915-25919, 1995.
8. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo Nature (Lond.), 359: 845-848, 1992.
9. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
10. Levitzki, A. Signal-transduction therapy. A novel approach to disease management. Eur. J. Biochem., 226: 1-13, 1994.
11. Koong, A. C., Chen, E. Y., and Giaccia, A. J. Hypoxia causes the activation of nuclear factor κB through the phosphorylation of IκBα on tyrosine residue. Cancer Res., 54: 1425-1430, 1994.
12. Laderoute, K. R., Murphy, B. J., Short, S. M., Grant, T. D., Knapp, A. M., and Sutherland, R. M. Enhancement of transforming growth factor-alpha synthesis in multicellular tumour spheroids of A431 squamous carcinoma cells. Br. J. Cancer., 65: 157-162, 1992.
13. Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., and Abraham, J. A. The human gene for vascular endothelial growth factor J. Biol. Chem., 266: 11947-11954, 1991.
14. Liu, H-S., Scrable, H., Villaret, D. B., Lieberman, M. A., and Stambrook, P. J. Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements. Cancer Res., 52: 983-989, 1992.
15. Finkenzeller, G., Technau, A., and Marme, D. Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem. Biophys. Res. Commun., 208: 432-439, 1995.
16. Wang, G. L., and Semenza, G. L. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem., 268: 21513-21518, 1993.
17. Stacey, D. W., Feig, L. A., and Gibbs, J. B. Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras. Mol. Cell. Biol., 11: 4053-4064, 1991.
18. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., Meli, S., and Gasparini, G. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst., 84: 1875-1887, 1992.
19. Okumeff, P., Dunphy, E. P., Hoeckel, M., Terris, D. J., and Vaupel, P. The role of oxygen tension distribution on the radiation response of human breast carcinoma. Adv. Exp. Med. Biol., 345: 485-492, 1994.
20. Warburg, O. On respiratory impairment in cancer cells Science (Washington DC), 124: 269-270, 1956.
21. Semenza, G. L., Roth, P. H., Fang, H., and Wang, G. L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem., 269: 23757-23763, 1994.